Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

654 ARTÍCULOS , VIENDO DEL 286 AL 300

Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis

Xing Y, Sapuan AH, Martín-Bastida A, Naidu S, Tench C, Evans J, Sare G, Schwarz ST, Al-Bachari S, Parkes LM, Kanavou S, Raw J, Silverdale M, Bajaj N, Pavese N, Burn D, Piccini P, Grosset DG, Auer DP.

Mov Disord. 2022 May;37(5):1028-1039. doi: 10.1002/mds.28934. Epub 2022 Feb 15.

A telephonic survey of health-related quality of life of outpatient department dropout Parkinson's disease patients during the COVID-19 pandemic

Goel A, Narayan SK, Sugumaran R.

Acta Neurol Belg. 2022 Apr;122(2):519-523. doi: 10.1007/s13760-022-01891-7. Epub 2022 Feb 17.

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism

Papathoma PE, Markaki I, Tang C, Lilja Lindström M, Savitcheva I, Eidelberg D, Svenningsson P.

Sci Rep. 2022 Feb 17;12(1):2763. doi: 10.1038/s41598-022-06663-0.

Meta-Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders

Behling E, Farhat LC, Landeros-Weisenberger A, Bloch MH.

Mov Disord. 2022 Apr;37(4):684-693. doi: 10.1002/mds.28957. Epub 2022 Feb 22.

Samba, deep water, and poles: a framework for exercise prescription in Parkinson's disease

Peyré-Tartaruga LA, Martinez FG, Zanardi APJ, Casal MZ, Donida RG, Delabary MS, Passos-Monteiro E, Coertjens M, Haas AN.

Sport Sci Health. 2022;18(4):1119-1127. doi: 10.1007/s11332-022-00894-4. Epub 2022 Feb 17.

Polygenic burden of Parkinson's disease risk stratifies the prognosis of isolated rapid-eye-movement disorder: A preliminary observational study

Tsukita K, Sakamaki-Tsukita H, Tachibana N, Takahashi R.

Parkinsonism Relat Disord. 2022 Mar;96:52-56. doi: 10.1016/j.parkreldis.2022.02.005. Epub 2022 Feb 19.

A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease

Rascol O, Medori R, Baayen C, Such P, Meulien D; AMBLED Study Group.

Mov Disord. 2022 May;37(5):1088-1093. doi: 10.1002/mds.28970. Epub 2022 Feb 26.

Fighting Parkinson's disease: The return of the mitochondria

Zambrano K, Barba D, Castillo K, Noboa L, Argueta-Zamora D, Robayo P, Arizaga E, Caicedo A, Gavilanes AWD.

Mitochondrion. 2022 May;64:34-44. doi: 10.1016/j.mito.2022.02.003. Epub 2022 Feb 24.

Botulinum toxin for the treatment of tremor

Mittal SO, Pandey S.

J Neurol Sci. 2022 Apr 15;435:120203. doi: 10.1016/j.jns.2022.120203. Epub 2022 Feb 19.

The MDS consensus tremor classification: The best way to classify patients with tremor at present

Latorre A, Hallett M, Deuschl G, Bhatia KP.

J Neurol Sci. 2022 Apr 15;435:120191. doi: 10.1016/j.jns.2022.120191. Epub 2022 Feb 19.

Neuromodulation of cognition in Parkinson's disease

Cole RC, Okine DN, Yeager BE, Narayanan NS.

Prog Brain Res. 2022;269(1):435-455. doi: 10.1016/bs.pbr.2022.01.016. Epub 2022 Feb 11.

Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk

Straniero L, Rimoldi V, Monfrini E, Bonvegna S, Melistaccio G, Lake J, Soldà G, Aureli M, Shankaracharya, Keagle P, Foroud T, Landers JE, Blauwendraat C, Zecchinelli A, Cilia R, Di Fonzo A, Pezzoli G, Duga S, Asselta R.

Mov Disord. 2022 Jun;37(6):1202-1210. doi: 10.1002/mds.28987. Epub 2022 Mar 9.

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease

Wang M, Liu H, Ma Z.

Front Cell Neurosci. 2022 Feb 21;16:832854. doi: 10.3389/fncel.2022.832854. eCollection 2022.

Bayesian Interpretation of Essential Tremor Plus

Elble RJ.

J Clin Neurol. 2022 Mar;18(2):127-139. doi: 10.3988/jcn.2022.18.2.127.

Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial

Chaudhuri KR, Odin P, Ferreira JJ, Antonini A, Rascol O, Kurtis MM, Storch A, Bannister K, Soares-da-Silva P, Costa R, Magalhães D, Rocha JF.

BMC Neurol. 2022 Mar 12;22(1):88. doi: 10.1186/s12883-022-02602-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias